Balance Sheet: Assets
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.
Paying user area
Try for free
Pfizer Inc. pages available for free this week:
- Income Statement
- Common-Size Income Statement
- Analysis of Liquidity Ratios
- Analysis of Geographic Areas
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
- Price to Earnings (P/E) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Pfizer Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Pfizer Inc., consolidated balance sheet: assets
US$ in millions
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
- Cash and Cash Equ equivalents
- The cash and cash equivalents exhibited significant fluctuations across the five-year period. After an initial increase from 1,784 million in 2020 to 1,944 million in 2021, there was a sharp decline to 416 million in 2022. This was followed by a substantial rise to 2,853 million in 2023 before decreasing again to 1,043 million in 2024.
- Short-term Investments
- Short-term investments showed variability, increasing markedly from 10,437 million in 2020 to 29,125 million in 2021. This was followed by a decrease to 22,316 million in 2022, a further decline to 9,837 million in 2023, and then a rebound to 19,434 million in 2024.
- Trade Accounts Receivable
- Trade accounts receivable saw consistent growth, rising from 7,930 million in 2020 to 11,463 million in 2024. There was a steady increase yearly, with a slight dip in 2022 but generally trending upwards, indicating growing sales or credit extended to customers.
- Inventories
- Inventory levels generally increased from 8,046 million in 2020 to 10,851 million in 2024. Minor fluctuations occurred but the overall trend was upward, suggesting buildup of stock possibly in anticipation of future sales or production needs.
- Current Tax Assets
- Current tax assets rose from 3,264 million in 2020 to a peak of 4,266 million in 2021, then declined to 3,314 million by 2024, reflecting variable tax positions across the periods.
- Other Current Assets
- Other current assets showed an upward trend from 3,439 million in 2020 to 5,299 million in 2023, before decreasing to 4,253 million in 2024, indicating changes in miscellaneous current asset categories.
- Current Assets of Discontinued Operations
- There was a value of 167 million recorded in 2020, after which no values were reported, suggesting the discontinuation of operations or disposal of these assets.
- Total Current Assets
- Total current assets increased substantially from 35,067 million in 2020 to a peak of 59,693 million in 2021, then decreased to 43,333 million in 2023 before partially recovering to 50,358 million in 2024, mirroring trends in cash, investments, and receivables.
- Equity-Method Investments
- Equity-method investments declined sharply from 16,856 million in 2020 to 217 million in 2024, indicating significant disposals or impairment in these investments over the period.
- Long-term Investments
- Long-term investments peaked at 5,054 million in 2021 but then steadily declined to 2,010 million by 2024, reflecting reductions in investment holdings or changes in classification.
- Property, Plant and Equipment, Net
- Net property, plant, and equipment increased consistently from 13,900 million in 2020 to 18,940 million in 2023, followed by a slight decrease to 18,393 million in 2024, suggesting ongoing capital expenditure with some asset retirements or disposals late in the period.
- Identifiable Intangible Assets, Net
- Identifiable intangible assets displayed strong growth from 28,471 million in 2020 to a peak of 64,900 million in 2023, then declined to 55,411 million in 2024. This pattern suggests acquisitions or asset revaluations in the middle years followed by some amortization or impairments.
- Goodwill
- Goodwill remained relatively stable from 49,577 million in 2020 to 49,208 million in 2021, then increased significantly to 68,527 million in 2024, pointing toward acquisition activity during the latter years.
- Noncurrent Deferred Tax Assets and Other Tax Assets
- This category rose significantly from 2,383 million in 2020 to 6,693 million in 2022, reduced to 3,706 million in 2023, then increased again to 8,662 million in 2024, indicating volatility possibly due to tax planning or timing differences.
- Other Noncurrent Assets
- Other noncurrent assets increased from 4,569 million in 2020 to 13,165 million in 2022, then gradually declined to 9,818 million in 2024, indicating fluctuations in long-term asset categories other than those specified.
- Total Noncurrent Assets
- Total noncurrent assets grew markedly from 119,162 million in 2020 to a peak of 183,168 million in 2023 before decreasing to 163,038 million in 2024, showing growth driven largely by intangible assets and goodwill, tempered by some declines in investments and other asset categories.
- Total Assets
- Total assets followed a strong upward trend from 154,229 million in 2020 to 226,501 million in 2023 before a moderate decline to 213,396 million in 2024, reflecting the combined effect of changes in current and noncurrent asset categories.